Key result
Ac-SDKP normalized DOCA-salt-induced albuminuria in hypertensive mice and prevented inflammatory cell infiltration and collagen deposition.
Why the study?
Does Ac-SDKP prevent renal damage in DOCA-salt hypertensive mice?
Does Ac-SDKP prevent renal damage in DOCA-salt hypertensive mice?
In a mouse model of low-renin hypertension, Ac-SDKP provided renoprotection by reducing inflammation, fibrosis, and albuminuria independently of blood pressure lowering.
Answers are grounded in this paper and cite their sources.
Ac-SDKP may confer renoprotection in low-renin hypertensive models; leaves open translation to human kidney disease.
BACKGROUND: Hypertension-induced renal injury is characterized by inflammation, fibrosis and proteinuria. Previous studies have demonstrated that N-acetyl-Ser-Asp-Lys-Pro (Ac-SDKP) inhibits renal damage following diabetes mellitus and antiglomerular basement membrane nephritis. However, its effects on low-renin hypertensive nephropathy are not known. Thus, we hypothesized that Ac-SDKP has renal protective effects on deoxycorticosterone acetate (DOCA)-salt hypertensive mice, decreasing inflammatory cell infiltration, matrix deposition and albuminuria. METHOD: We uninephrectomized 16-week-old C57BL/6J mice and treated them with either placebo, DCOA (10 mg/10 g body weight subcutaneous) and 1% sodium chloride with 0.2% potassium chloride in drinking water (DOCA-salt) or DOCA-salt with Ac-SDKP (800 μg/kg per day) for 12 weeks. We measured blood pressure, urine albumin, glomerular matrix, renal collagen content, monocyte/macrophage infiltration and glomerular nephrin expression. RESULTS: Treatment with DOCA-salt significantly increased blood pressure (P < 0.01), which remained unaltered by Ac-SDKP. Ac-SDKP decreased DOCA-salt-induced renal collagen deposition, glomerular matrix expansion and monocyte/macrophage infiltration. Moreover, DOCA-salt-induced increase in albuminuria was normalized by Ac-SDKP (controls, 10.8 ± 1.7; DOCA-salt, 41 ± 5; DOCA-salt + Ac-SDKP, 13 ± 3 μg/10 g body weight per 24 h; P < 0.001, DOCA-salt vs. DOCA-salt + Ac-SDKP). Loss of nephrin reportedly causes excess urinary protein excretion; therefore, we determined whether Ac-SDKP inhibits proteinuria by restoring nephrin expression in the glomerulus of hypertensive mice. DOCA-salt significantly downregulated glomerular nephrin expression (controls, 37 ± 8; DOCA-salt, 10 ± 1.5% of glomerular area; P < 0.01), which was partially reversed by Ac-SDKP (23 ± 4.0% of glomerular area; P = 0.065, DOCA-salt vs. DOCA-salt + Ac-SDKP). CONCLUSION: We concluded that Ac-SDKP prevents hypertension-induced inflammatory cell infiltration, collagen deposition, nephrin downregulation and albuminuria, which could lead to renoprotection in hypertensive mice.
No takes yet. Share an insight, caveat, or question.
Rhaleb et al. (2010) studied Hypertension-induced renal injury. N-acetyl-Ser-Asp-Lys-Pro (Ac-SDKP) vs. DOCA-salt alone was evaluated on Albuminuria (μg/10 g body weight per 24 h) (p=<0.001). Ac-SDKP normalized DOCA-salt-induced albuminuria in hypertensive mice and prevented inflammatory cell infiltration and collagen deposition.
Synapse has enriched 10 related papers. Consider them for comparative context: